Vittal Vasista, Chief Financial Officer at REGENXBIO Inc. (RGNX), sold 7,500 shares at $45.73 ($348K) on 2018-12-17, disclosed to the SEC on 2018-12-19.
Open-market sale of $348k RGNX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.73 | 4,100 | $187K | 53.9% |
| 2 | $46.47 | 1,700 | $79K | 22.7% |
| 3 | $47.74 | 1,700 | $81K | 23.3% |
| Total | $46.35 avg | 7,500 | $348K | 100% |
| Filing → |
| RGNX | SELL | 2022-08-03 | $75K | — | Filing → |
| RGNX | SELL | 2022-07-15 | $274K | — | Filing → |
| RGNX | SELL | 2021-01-20 | $13K | — | Filing → |